Suppression of proteoglycan synthesis by calcium ionophore A23187 in cultured vascular endothelial cells: Implication of intracellular calcium accumulation in lead inhibition of endothelial proteoglycan synthesis

Journal of Health Science

Volumn 48, Issue 5, 2002, Pages 460-466

  Fujiwara, Yasuyuki ^a   Kaji, Toshiyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Calcium; Endothelial cell; Glycosaminoglycan; Heparan sulfate; Lead; Proteoglycan

Indexed keywords

2 DIETHYLAMINOETHANOL; CALCIMYCIN; CALCIUM; CETYLPYRIDINIUM SALT; HEAVY METAL; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SULFATE; SULFUR 35;

ANIMAL CELL; ANIMAL CELL CULTURE; AORTA; ARTICLE; ATHEROGENESIS; BIOACCUMULATION; CALCIUM CELL LEVEL; CHEMICAL ANALYSIS; CHEMICAL LABELING; CONTROLLED STUDY; COW; DOWN REGULATION; INHIBITION KINETICS; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; PRECIPITATION; PROTEOGLYCAN SYNTHESIS; VASCULAR ENDOTHELIUM;

ANIMALIA; BOVINAE;

EID: 24744459843     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.48.460     Document Type: Article

References (42)

1. Sato, Y. and Rifkin, D. B. (1988) Autocrine activities of bovine basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell Biol., 107, 1199-1205.
2. Ruoslahti, E. and Yamaguchi, Y. (1991) Proteoglycans as modulators of growth factor activities. Cell, 64, 867-869.
3. Rusnati, M. and Presta, M. (1996) Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int. J. Clin. Lab. Res., 26, 15-23.
4. Kaji, T., Inada, M., Yamamoto, C., Fujiwara, Y. and Koizumi, F. (1996) Cyclic AMP-dependent pathway that mediates suppressive regulation of glycosaminoglycan production in cultured vascular endothelial cells. Thromb. Res., 82, 389-397.
5. Fujii, N., Kaji, T., Yamamoto, C., Fujiwara, Y. and Koizumi, F. (1996) Phorbol 12-myristate 13-acetate stimulates the release of glycosaminoglycans from cultured vascular endothelial cells: possible involvement of protein kinase C activation. Thromb. Res., 82, 379-387.
6. Yamamoto, C., Kaji, T., Sakamoto, M., Kozuka, H. and Koizumi, F. (1994) Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells. Thromb. Res., 74, 163-168.
7. Fujiwara, Y. and Kaji, T. (1999) Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture. Toxicology, 133, 159-169.
8. Fujiwara, Y. and Kaji, T. (1999) Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis. Toxicology, 133, 147-157.
9. Kaji, T., Fujiwara, Y., Hoshino, M., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1995) Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells. Toxicology, 95, 87-92.
10. Fujiwara, Y., Kaji, T., Sakurai, S., Sakamoto, M. and Kozuka, H. (1997) Inhibitory effect of lead on the repair of wounded monolayers of cultured vascular endothelial cells. Toxicology, 117, 193-198.
11. Fujiwara, Y. and Kaji, T. (2000) Inhibition of the repair of injured endothelial cell monolayers by lead and its possible mechanisms. J. Health Sci., 46, 1-4.
12. Yamamoto, T., Yamaguchi, M. and Suketa, Y. (1974) Calcium accumulation in liver and calcium mobilization in bone of lead-poisoned rats. Toxicol. Appl. Pharmacol., 27, 204-205.
13. Goldstein, G. W., Wolinsky, J. S. and Csejtey, J. (1977) Isolated brain capillaries: a model for the study of lead encephalopathy. Ann. Neurol., 1, 235-239.
14. Piccinini, F., Favalli, L. and Chiari, M. C. (1977) Experimental investigations on the contraction induced by lead in arterial smooth muscle. Toxicology, 8, 43-51.
15. Pounds, J. G., Wright, R., Morrison, D. and Casciano, D. A. (1982) Effect of lead on calcium homeostasis in the isolated rat hepatocyte. Toxicol. Appl. Pharmacol., 63, 389-401.
16. 2+ by 19F NMR. Proc. Natl. Acad. Sci. U.S.A., 86, 5133-5135.
17. Schanne, F. A., Long, G. J. and Rosen, J. F. (1997) Lead induced rise in intracellular free calcium is mediated through activation of protein kinase C in osteoblastic bone cells. Biochim. Biophys. Acta, 1360, 247-254.
18. Goldstein, G. W. and Ar, D. (1983) Lead activates calmodulin sensitive process. Life Sci., 33, 1001-1006.
19. 2+ in calmodulin. Arch. Toxicol., 54, 61-70.
20. Wasteson, Å., Uthne, K. and Westermark, B. (1973) A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effect of somatomedin on cultured cells. Biochem. J., 136, 1069-1074.
21. Kaji, T., Yamada, A., Miyajima, S., Yamamoto, C., Fujiwara, Y., Wight, T. N. and Kinsella, M. G. (2000) Cell density-dependent regulation of proteoglycan synthesis by transforming growth factor-b1 in cultured bovine aortic endothelial cells. J. Biol. Chem., 275, 1463-1470.
22. Blazka, M. E. and Shaikh, Z. A. (1991) Differences in cadmium and mercury uptakes by hepatocytes: role of calcium channels. Toxicol. Appl. Pharmacol., 110, 355-363.
23. Kissane, J. M. and Robins, E. (1958) The fluorometric measurement of deoxyribonucleic acid in animal tissue with special reference to the central nervous system. J. Biol. Chem., 233, 184-188.
24. Kinsella, M. G. and Wight, T. N. (1986) Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J. Cell Biol., 102, 679-687.
25. Vijayagopal, P. and Subramaniam, P. (2001) Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein-proteoglycan interaction. Atherosclerosis, 157, 353-360.
26. Fagnen, G., Phamantu, N. T., Bocquet, J. and Bonnamy, P. J. (1999) Inhibition of transmembrane calcium influx induces decrease in proteoglycan synthesis in immature rat Sertoli cells. J. Cell. Biochem., 76, 322-331.
27. Lenz, R. W., Ax, R. L. and First, N. L. (1982) Proteoglycan production by bovine granulosa cells in vitro is regulated by calmodulin and calcium. Endocrinology, 110, 1052-1054.
28. Parvizi, J., Parpura, V., Greenleaf, J. F. and Bolander, M. E. (2002) Calcium signaling is required for ultrasound-stimulated aggrecan synthesis by rat chondrocytes. J. Orthop. Res., 20, 51-57.
29. Nishisaka, F., Sohen, S., Fukuoka, H., Okamoto, Y., Matukawa. M., Fukuda, K. and Hamanishi, C. (2001) Interleukin-4 reversed the interleukin-1-inhibited proteoglycan synthesis through the inhibition of NO release: a possible involvement of intracellular calcium ion. Pathophysiology, 7, 289-293.
30. Fujiwara, Y., Kaji, T., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1995) Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells. Toxicology, 98, 105-110.
31. Simons, T. J and Pocock, G. (1987) Lead enters bovine adrenal medullary cells through calcium channels. J. Neurochem., 48, 383-389.
32. 2+ entry in isolated bovine chromaffin cells. Biochim. Biophys. Acta, 1069, 197-200.
33. Busselberg, D. (1995) Calcium channels as target sites of heavy metals. Toxicol. Lett., 82-83, 255-261.
34. Yamamoto, C. and Kaji, T. (1999) Effect of lead on the synthesis of tissue plasminogen activator by vascular endothelial cells in culture. J. Health Sci., 45, 119-125.
35. Schachter, M. (1997) Calcium antagonists and atherosclerosis. Int. J. Cardiol., 62, S9-S15.
36. Weinstein, D. B. and Heider, J. G. (1989) Antiatherogenic properties of calcium antagonists. State of the art. Am. J. Med., 86, 27-32.
37. Weinstein, D. B. and Heider, J. G. (1989) Protective action of calcium channel antagonists in atherogenesis and experimental vascular injury. Am. J. Hypertens., 2, 205-212.
38. Mertens, G., Cassiman, J. J., Van den Berghe, H., Vermylen, J. and David, G. (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J. Biol. Chem., 267, 20435-20443.
39. Whinna, H. C., Choi, H. U., Rosenberg, L. C. and Church, F. C. (1993) Interaction of heparin cofactor II with biglycan and decorin. J. Biol. Chem., 268, 3920-3924.
40. Revis, N. W., Zinsmeister, A. R. and Bull, R. (1981) Atherosclerosis and hypertension induced by lead and cadmium ions: an effect prevented by calcium ion. Proc. Natl. Acad. Sci. U.S.A., 78, 6494-6498.
41. Pirkle, J. L., Schwartz, J., Landis, J. R. and Harlan, W. R. (1985) The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol., 121, 246-258
42. Schwartz, J. (1991) Lead, blood pressure, and cardiovascular disease in men and women. Environ. Health Perspect., 91, 71-75.